Paper Details

  1. Home
  2. Paper Details

Platelet-oriented inhibition in new TIA and minor ischemic stroke (POINT) trial: rationale and design.

Author: BarsanWilliam, BattenhouseHolly, ConwitRobin, DillonCatherine, EastonJ Donald, ElmJordan, FarrantMary, JohnstonS Claiborne, LindbladAnne, MorgensternLewis, PaleschYuko, PoissonSharon N

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, N.I.H., ExtramuralResearch funding provided by the NIH to external research institutions and researchers.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.
Research Support, U.S. Gov't, Non-P.H.S.Research funding provided by US government agencies other than the Public Health Service.

Overview

Within the first three months after a transient ischemic attack (TIA) or minor stroke, 10-20% of people experience another stroke or other vascular problems, many of which are disabling. The highest risk period is in the hours and days immediately following the initial event. Aspirin is the most common medication used to prevent blood clots in these patients.
Paper Details　
Original Abstract of the Article :
Ischemic stroke and other vascular outcomes occur in 10-20% of patients in the three-months following a transient ischemic attack or minor ischemic stroke, and many are disabling. The highest risk period for these outcomes is the early hours and days immediately following the ischemic event. Aspirin...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/23879752

データ提供：米国国立医学図書館（NLM）
in preparation
Date :
  1. Date Completed 2014-04-08
  2. Date Revised 2022-03-18
Further Info :

Pubmed ID

23879752

DOI: Digital Object Identifier

NIHMS477130

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.